Literature DB >> 26816073

Efficacy of N-acetylcysteine on neuroclinical, biochemical, and histopathological parameters in experimental spinal cord trauma: comparison with methylprednisolone.

U Y Çavuş1, A Yılmaz2, M N Aytekin3, G Taburcu4, A Albayrak5, S Yıldırım6, I Ağır7.   

Abstract

BACKGROUND: N-acetylcysteine (NAC) is an antioxidant agent that has been shown to have beneficial effects when treating various diseases. The aim of this study was to investigate the effects of NAC on spinal cord injury in an experimental rat model.
METHODS: A total of 48 adult male wistar albino rats were divided into six groups. Group C included the control rats, group L included the rats that underwent laminectomy, and group T included the rats in which spinal cord trauma was induced by the weight-drop method after laminectomy. Groups M (the methylprednisolone group), N (the NAC group), and MN (the methylprednisolone + NAC group) were the treatment groups. In the fourth group (group M), 30 mg/kg methylprednisolone (MP) was administered as a bolus intraperitoneally (IP), and a standard MP treatmentat a dose of 5.4 mg/kg was applied for 24 h. In the fifth group (group N), only 300 mg/kg NAC was administered as a bolus IP. In the sixth group (group MN), the standard MP treatment and a single 300 mg/kg dose of NAC were administered as a bolus IP. The motor functions of the rats were evaluated on the 1st, 7th, and 14th days using the inclined plane test defined by Rivlin and Tator and the motor scale defined by Gale et al. Spinal cord samples were obtained on the 14th day. The samples were evaluated using pathological and biochemical analysis.
RESULTS: In the neuroclinical assessment, no differences were observed between groups T and M in terms of motor improvement. However, statistically significant differences were observed between group T and groups N and MN (p < 0.001, p = 0.01, respectively). Statistically significant differences were also seen between group M and groups N and MN on the 1st and 7th days (p < 0.017, p < 0.01, respectively). Additionally, when groups N and MN were compared with groups T and M,the pathological and biochemical analyses were found to be statistically different (p < 0.05, p < 0.001, respectively).
CONCLUSION: It was concluded that NAC treatment and the combined NAC + MP treatment may be more useful for healing in rats with experimental spinal cord injury in terms of neuroclinical, pathological, and biochemical results than MP-only therapy.

Entities:  

Keywords:  Methylprednisolone; N-acetylcysteine; Rat model; Spinal cord injury

Year:  2013        PMID: 26816073     DOI: 10.1007/s00068-013-0349-4

Source DB:  PubMed          Journal:  Eur J Trauma Emerg Surg        ISSN: 1863-9933            Impact factor:   3.693


  34 in total

1.  Neuroprotective effects of N-acetylcysteine on experimental closed head trauma in rats.

Authors:  Tufan Hicdonmez; Mehmet Kanter; Mehmet Tiryaki; Turgay Parsak; Sebahattin Cobanoglu
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

Review 2.  Pharmacological interventions for spinal cord injury: where do we stand? How might we step forward?

Authors:  Alexander G Rabchevsky; Samir P Patel; Joe E Springer
Journal:  Pharmacol Ther       Date:  2011-05-14       Impact factor: 12.310

3.  The biochemical effectiveness of N-acetylcysteine in experimental spinal cord injury in rats.

Authors:  Volkan Hanci; Alaeddin Kerimoğlu; Kenan Koca; Aykut Başkesen; Kemal Kiliç; Didem Taştekin
Journal:  Ulus Travma Acil Cerrahi Derg       Date:  2010-01

4.  Neuroprotection by acetyl-L-carnitine after traumatic injury to the immature rat brain.

Authors:  Susanna Scafidi; Jennifer Racz; Julie Hazelton; Mary C McKenna; Gary Fiskum
Journal:  Dev Neurosci       Date:  2011-01-12       Impact factor: 2.984

5.  N-acetylcysteine attenuates early induction of heme oxygenase-1 following traumatic brain injury.

Authors:  Jae-Hyuk Yi; Alan S Hazell
Journal:  Brain Res       Date:  2005-02-01       Impact factor: 3.252

6.  High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients.

Authors:  T Qian; X Guo; A D Levi; S Vanni; R T Shebert; M L Sipski
Journal:  Spinal Cord       Date:  2005-04       Impact factor: 2.772

7.  Effect of melatonin on ischemia reperfusion injury induced by middle cerebral artery occlusion in rats.

Authors:  K Sinha; M N Degaonkar; N R Jagannathan; Y K Gupta
Journal:  Eur J Pharmacol       Date:  2001-10-05       Impact factor: 4.432

8.  Effects of resveratrol and methylprednisolone on biochemical, neurobehavioral and histopathological recovery after experimental spinal cord injury.

Authors:  Ozkan Ates; Suleyman Cayli; Eyup Altinoz; Iclal Gurses; Neslihan Yucel; Ayhan Kocak; Saim Yologlu; Yusuf Turkoz
Journal:  Acta Pharmacol Sin       Date:  2006-10       Impact factor: 6.150

9.  Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke.

Authors:  Mushfiquddin Khan; Bipanjeet Sekhon; Manu Jatana; Shailendra Giri; Anne G Gilg; Charanpal Sekhon; Inderjit Singh; Avtar K Singh
Journal:  J Neurosci Res       Date:  2004-05-15       Impact factor: 4.164

Review 10.  Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects.

Authors:  C H Tator
Journal:  Neurochirurgie       Date:  1991       Impact factor: 1.553

View more
  1 in total

1.  Advanced Age and Neurotrauma Diminish Glutathione and Impair Antioxidant Defense after Spinal Cord Injury.

Authors:  Andrew N Stewart; Ethan P Glaser; Caitlin A Mott; William M Bailey; Patrick G Sullivan; Samir P Patel; John C Gensel
Journal:  J Neurotrauma       Date:  2022-07-13       Impact factor: 4.869

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.